Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Risk stratification and mitigation in multiple sclerosis.
Multiple sclerosis: Blood-based biomarkers provide insight into progressive MS.
Management of fatigue in persons with multiple sclerosis.
Exclusive use of alternative medicine as a positive choice: a qualitative study of treatment assumptions among people with multiple sclerosis in denmark.
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.
Persistence and pathogenesis of the neurotropic polyomavirus JC.
Multiple sclerosis following anti-tumor necrosis factor-alpha therapy for psoriasis: first case in Italy? Case report and review of the literature.
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
Impaired sleep-associated modulation of post-exercise corticomotor depression in multiple sclerosis.
Inhibition of Interferon regulatory factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Aquaporin-4 autoimmunity.
The Perspectives of Iranian Patients With Multiple Sclerosis on Continuity of Care: A Qualitative Study.
Visual pathway neurodegeneration winged by mitochondrial dysfunction.
Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9.
[Stem cell transplantation for multiple sclerosis : Hamburg experiences and state of international research].
Drugs that Treat Skin Conditions May Help Combat Multiple Sclerosis.
Research Findings on Overactive Bladder.
Prorating WAIS-IV Summary Scores for Patients with Relapsing-Remitting Multiple Sclerosis.
Myelin-specific T cells induce interleukin-1beta expression in lesion-reactive microglial-like cells in zones of axonal degeneration.
Core muscle characteristics during walking of patients with multiple sclerosis.
A Case Report of Post Rabipur (Purified Chick Embryo Rabies Vaccine) Acute Disseminated Encephalomyelitis.
Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.
Efficacy and Safety of Fingolimod in an Unselected Patient Population.
Visualisation of the medial longitudinal fasciculus using fibre tractography in multiple sclerosis patients with internuclear ophthalmoplegia.
Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigue.
Pages
« first
‹ previous
…
450
451
452
453
454
455
456
457
458
…
next ›
last »